Drugs / Td
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03615404 Background | Oct 2018 → Nov 2019 | brain cancer, glioblastoma, medulloblastoma | Gary Archer Ph.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Td | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03615404 ↗ |
| Modality | Vaccine | “Td vaccine as adjuvants” NCT03615404 ↗ |